Nexense is a leading R&D company founded in 2001 partly held by GE Healthcare.
Nexense developed a unique sensors platform capable of measuring most physical parameters close to molecular precision with signal to noise ratio that exceeds the state of the art.
This sensors platform produces measurements in a direct digital format, eliminating the need to convert from analog and thus maintaining extreme accuracy with regard to the actual values being measured.
This allows for the precise measurement of physiological parameters without requiring physical contact. So, for example, the Snoring Care system identifies snoring and apnea without any physical contact being made with the snorer using a sensor placed beneath the snorer’s bed. This same platform of sensors also precisely measures the pulse and breathing of a baby weighing 1 kg by means of a sensor placed beneath the mattress.
Fortune 500 companies including: Samsung, Ford, General Motors, Johnson & Johnson and others used Nexense’s sensing platform to develop new products or to enhance existing products and applications.
Nexense sensors platform and its IP was also rated by Teus as highly unique and is protected by over 50 patents and applications world wide.
Nexense develops innovative products and collaborates with world leading companies and Physicians in order to focus on non intrusive devices that treat prevalence disorders effectively. Using our sensors platform we can measure and identify all vital signals in different sites with minimum touch.
Snoring Care™ is a result of five years of intensive R&D and is one of Nexense’s most innovative and effective under the mattress products. Snoring care™ complies with all regulations including TUV, FCC, and ISO-9001: 2000 and ISO-13485: 2003 and CE Mark and is recommended by Otolaryngologists, surgeons and family practitioners.